-
More Than a SignatureThe informed consent process is designed to ensure that patients understand risks. But new advances involved in genetic testing and tissue donation may make signing on the dotted line more complex than ever.
by Stephen Ornes
-
Q&A
Support in Any LanguagePatient advocate Ivis Febus-Sampayo promotes support services for cancer patients in minority communities.
by Marci A. Landsmann
-
Forward Look
Fueling the Pediatric Cancer PipelineNew efforts are needed to push the pace of drug development.
by Leah Lawrence
-
Forward Look
It Takes a VillageImproving pediatric cancer care in developing countries
by Leah Lawrence
-
Forward Look
Identifying the Unexpected Risks of Targeted TherapyDrugs designed to single out cancer cells also may have side effects.
by Melissa Weber
-
Forward Look
Get Smart About Smartphone Cancer AppsStudy shows reasons to be skeptical about medical apps.
by Stephen Ornes
-
When Less Is MoreStudies are finding that aggressive treatment, such as extensive surgery, radiation or chemotherapy, is not always necessary for cancer patients to get good results.
by Alexandra Goho
-
No Through RoadCancer cells are able to find new pathways around targeted therapies. Scientists are racing to get there first.
by Sue Rochman
-
Healthy Habits
It Takes All KindsA variety of vegetables and fruit can help reduce your cancer risk
by Marci A. Landsmann
-
Q&A
The Legacy of Henrietta LacksAuthor Rebecca Skloot reflects on the contributions of one woman to science and the importance of informed consent in human research.
by Alexandra Goho
After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
